News & Insights

• Caristo Diagnostics has raised £13m to advance its CaRi-Heart® technology, an AI-assisted heart imaging tool capable of predicting risk of future heart attacks.
• The round was led by Oxford Science Enterprises with participation from BGF, Longwall Venture Partners and Oxford University.

• SpyBiotech has received a grant of $4m from the Bill & Melinda Gates Foundation to further develop its novel vaccine technology.
• This project will harness SpyBio’s ‘plug and display’ technology to design a broadly cross-protective coronavirus vaccine.

• Mind Foundry, an Oxford University spinout that develops AI for high-stakes applications, has announced a continuation of their successful collaboration with the Aioi Nissay Dowa group.
• The Aioi R&D Lab will focus on developing real-world AI solutions to major societal challenges through better insurance.

Christopher tells us about how he is applying his experience in law and corporate finance to early-stage tech investment in Oxford.

• Diffblue has raised $8m to expand its product’s functionality and target a $40m market opportunity.
• The round was led by Albion VC with participation from IP Group, Parkwalk and Hostplus.
• This investment brings Diffblue’s total venture funding to $40m to date.